Zimmer Biomet Holdings Inc. (NYSE: ZBH) Stock News & Analysis
Zimmer Biomet Holdings Inc. (NYSE: ZBH) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 1 article on ZBH since Wednesday, July 1, 2026, most recently "Zimmer Biomet to Acquire iovera° Device from Pacira BioSciences for $140M" on Wednesday, July 1, 2026. Coverage to date spans Health Care, tracking ZBH's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
ZBH Coverage -- 1 Article
Zimmer Biomet to Acquire iovera° Device from Pacira BioSciences for $140M
Zimmer Biomet is paying $140M to acquire the iovera° device from Pacira, with milestone payments stretching through December 2031.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.